glp-1 agonists with cardiovascular benefit The effects of receptor beyond obesity and type 2 diabetes: An anti-atherosclerotic action GLP-1 receptor agonists and cardiovascular

The goal is to keep IGF-1 in an appropriate range, not to maximize it, because IGF-1 is a growth signal and excessive levels raise concerns over time

Emotional Brain Processing: Fascinating recent studies published in the Journal of Clinical Investigation have shown that Kisspeptin actually alters the way our brains process emotions

When NNMT is active, it depletes the cell of NAD+, a critical molecule for energy production

In a study, NAD-229 antagonist for the 5-HT1A receptor and TCB-2 antagonists for the 5-HT2A receptor were able to prevent the progression of AD by reducing neuronal loss and oxidative stress in an AD model (Wistar rats) induced with streptozotocin [167] (Fig

1) illustrates the study selection process